Search Results - "Margeson, Dean"

IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study by MARCUCCI, Guido, MAHARRY, Kati, METZELER, Klaus H, POWELL, Bayard L, CARTER, Thomas H, KOLITZ, Jonathan E, WETZLER, Meir, CARROLL, Andrew J, BAER, Maria R, CALIGIURI, Michael A, LARSON, Richard A, BLOOMFIELD, Clara D, WU, Yue-Zhong, RADMACHER, Michael D, MROZEK, Krzysztof, MARGESON, Dean, HOLLAND, Kelsi B, WHITMAN, Susan P, BECKER, Heiko, SCHWIND, Sebastian

“…PURPOSE To analyze the frequency and associations with prognostic markers and outcome of mutations in IDH genes encoding isocitrate dehydrogenases in adult de…”
Get full text

TET2 Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study by METZELER, Klaus H, MAHARRY, Kati, WU, Yue-Zhong, BLUM, William, POWELL, Bayard L, CARTER, Thomas H, WETZLER, Meir, MOORE, Joseph O, KOLITZ, Jonathan E, BAER, Maria R, CARROLL, Andrew J, LARSON, Richard A, RADMACHER, Michael D, CALIGIURI, Michael A, MARCUCCI, Guido, BLOOMFIELD, Clara D, MROZEK, Krzysztof, MARGESON, Dean, BECKER, Heiko, CURFMAN, John, HOLLAND, Kelsi B, SCHWIND, Sebastian, WHITMAN, Susan P

“…To determine the frequency of TET2 mutations, their associations with clinical and molecular characteristics and outcome, and the associated gene- and…”
Get full text

Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study by BECKER, Heiko, MARCUCCI, Guido, POWELL, Bayard L, CARTER, Thomas H, KOLITZ, Jonathan E, WETZLER, Meir, CARROLL, Andrew J, BAER, Maria R, CALIGIURI, Michael A, LARSON, Richard A, BLOOMFIELD, Clara D, MAHARRY, Kati, RADMACHER, Michael D, MROZEK, Krzysztof, MARGESON, Dean, WHITMAN, Susan P, WU, Yue-Zhong, SCHWIND, Sebastian, PASCHKA, Peter

“…To analyze the prognostic significance of NPM1 mutations, and the associated gene- and microRNA-expression signatures in older patients with de novo,…”
Get full text

Prognostic Significance of Expression of a Single MicroRNA, miR-181a, in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study by SCHWIND, Sebastian, MAHARRY, Kati, PASCHKA, Peter, BALDUS, Claudia D, SHUJUN, Liu, GARZON, Ramiro, POWELL, Bayard L, KOLITZ, Jonathan E, CARROLL, Andrew J, CALIGIURI, Michael A, LARSON, Richard A, MARCUCCI, Guido, RADMACHER, Michael D, BLOOMFIELD, Clara D, MROZEK, Krzysztof, HOLLAND, Kelsi B, MARGESON, Dean, WHITMAN, Susan P, HICKEY, Christopher, BECKER, Heiko, METZELER, Klaus H

“…To evaluate the prognostic significance of expression levels of a single microRNA, miR-181a, in the context of established molecular markers in cytogenetically…”
Get full text

Growth and Development in Preterm Infants Fed Long-Chain Polyunsaturated Fatty Acids: A Prospective, Randomized Controlled Trial by O'Connor, Deborah L, Hall, Robert, Adamkin, David, Auestad, Nancy, Castillo, Marcella, Connor, William E, Connor, Sonja L, Fitzgerald, Kathleen, Groh-Wargo, Sharon, Hartmann, E. Eugenie, Jacobs, Joan, Janowsky, Jeri, Lucas, Alan, Margeson, Dean, Mena, Patricia, Neuringer, Martha, Nesin, Mirjana, Singer, Lynn, Stephenson, Terence, Szabo, Joanne, Zemon, Vance, on behalf of Ross Preterm Lipid Studya

“…A randomized, masked, controlled trial was conducted to assess effects of supplementing premature infant formulas with oils containing the long-chain…”
Get full text

Growth and Development of Premature Infants Fed Predominantly Human Milk, Predominantly Premature Infant Formula, or a Combination of Human Milk and Premature Formula by O'Connor, Deborah L., Jacobs, Joan, Hall, Robert, Adamkin, David, Auestad, Nancy, Castillo, Marcella, Connor, William E., Connor, Sonja L., Fitzgerald, Kathleen, Groh-Wargo, Sharon, Hartmann, E. Eugenie, Janowsky, Jeri, Lucas, Alan, Margeson, Dean, Mena, Patricia, Neuringer, Martha, Ross, Gail, Singer, Lynn, Stephenson, Terence, Szabo, Joanne, Zemon, Vance

Get full text

Reduced Bone Mineralization in Infants Fed Palm Olein-Containing Formula: A Randomized, Double-Blinded, Prospective Trial by Koo, Winston W. K, Hammami, Mouhanad, Margeson, Dean P, Nwaesei, Chuks, Montalto, Michael B, Lasekan, John B

“…Palm and palm olein (PO) oils are used in some infant formula fat blends to match the fatty acid profile of human milk, but their presence has been shown to…”
Get full text

FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study by Whitman, Susan P., Maharry, Kati, Radmacher, Michael D., Becker, Heiko, Mrózek, Krzysztof, Margeson, Dean, Holland, Kelsi B., Wu, Yue-Zhong, Schwind, Sebastian, Metzeler, Klaus H., Wen, Jing, Baer, Maria R., Powell, Bayard L., Carter, Thomas H., Kolitz, Jonathan E., Wetzler, Meir, Moore, Joseph O., Stone, Richard M., Carroll, Andrew J., Larson, Richard A., Caligiuri, Michael A., Marcucci, Guido, Bloomfield, Clara D.

“…The clinical impact of FLT3-internal tandem duplications (ITDs), an adverse prognostic marker in adults aged < 60 years with primary cytogenetically normal…”
Get full text

BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study by Schwind, Sebastian, Marcucci, Guido, Maharry, Kati, Radmacher, Michael D., Mrózek, Krzysztof, Holland, Kelsi B., Margeson, Dean, Becker, Heiko, Whitman, Susan P., Wu, Yue-Zhong, Metzeler, Klaus H., Powell, Bayard L., Kolitz, Jonathan E., Carter, Thomas H., Moore, Joseph O., Baer, Maria R., Carroll, Andrew J., Caligiuri, Michael A., Larson, Richard A., Bloomfield, Clara D.

“…BAALC and ERG expression levels are prognostic markers in younger (< 60 years) cytogenetically normal acute myeloid leukemia (CN-AML) adults; their prognostic…”
Get full text

Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study by Becker, Heiko, Marcucci, Guido, Maharry, Kati, Radmacher, Michael D., Mrózek, Krzysztof, Margeson, Dean, Whitman, Susan P., Paschka, Peter, Holland, Kelsi B., Schwind, Sebastian, Wu, Yue-Zhong, Powell, Bayard L., Carter, Thomas H., Kolitz, Jonathan E., Wetzler, Meir, Carroll, Andrew J., Baer, Maria R., Moore, Joseph O., Caligiuri, Michael A., Larson, Richard A., Bloomfield, Clara D.

“…We previously reported the adverse prognostic impact of Wilms tumor 1 gene (WT1) mutations in younger adult cytogenetically normal acute myeloid leukemia…”
Get full text

DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication by Whitman, Susan P., Hackanson, Björn, Liyanarachchi, Sandya, Liu, Shujun, Rush, Laura J., Maharry, Kati, Margeson, Dean, Davuluri, Ramana, Wen, Jing, Witte, Tatiana, Yu, Li, Liu, Chunhui, Bloomfield, Clara D., Marcucci, Guido, Plass, Christoph, Caligiuri, Michael A.

“…Posttranslationally modified histones and DNA hypermethylation frequently interplay to deregulate gene expression in cancer. We report that acute myeloid…”
Get full text

Mutations In the Tet Oncogene Family Member 2 (TET2) Gene Refine the New European LeukemiaNet Risk Classification of Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) In Adults: A Cancer and Leukemia Group B (CALGB) Study by Metzeler, Klaus H., Maharry, Kati, Radmacher, Michael D., Mrózek, Krzysztof, Margeson, Dean, Becker, Heiko, Curfman, John, Holland, Kelsi B., Schwind, Sebastian, Whitman, Susan P., Wu, Yue-Zhong, Blum, William, Powell, Bayard L., Carter, Thomas H., Wetzler, Meir, Moore, Joseph O., Kolitz, Jonathan E., Baer, Maria R., Carroll, Andrew J., Larson, Richard A., Caligiuri, Michael A., Marcucci, Guido, Bloomfield, Clara D.

“…Abstract 98 Mutations in the TET2 gene were recently identified in a variety of myeloid neoplasms including AML. However, the frequency and clinical relevance…”
Get full text

Sole Trisomy 8 In Patients (pts) with De Novo Acute Myeloid Leukemia (AML) Is Associated with Age-Independent Poor Outcome That Is Modified by Molecular Markers and with Unique Gene- and Microrna (miR)-Signatures: a Cancer and Leukemia Group B (CALGB) Study by Becker, Heiko, Maharry, Kati, Radmacher, Michael D., Margeson, Dean, Mrózek, Krzysztof, Whitman, Susan P., Wu, Yue-Zhong, Metzeler, Klaus H., Schwind, Sebastian, Holland, Kelsi B., Kolitz, Jonathan E., Carroll, Andrew J., Caligiuri, Michael A., Baer, Maria R., Larson, Richard A., Marcucci, Guido, Bloomfield, Clara D.

“…Abstract 577 Trisomy 8 (+8), the most frequent numerical aberration in AML, occurs in approximately 10% of pts. In one-third of them, +8 is the sole chromosome…”
Get full text

Prognostic Significance of Unbalanced Chromosome Abnormalities Used by 2008 World Health Organization (WHO) Classification to Define “Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes” in Adults: a Cancer and Leukemia Group B (CALGB) Study by Mrózek, Krzysztof, Holland, Kelsi B., Pettenati, Mark J., Maharry, Kati, Marcucci, Guido, Baer, Maria R., Kolitz, Jonathan E., Margeson, Dean, Edwards, Colin G., Carroll, Andrew J., Larson, Richard A., Bloomfield, Clara D.

“…Abstract 2602▪▪This icon denotes an abstract that is clinically relevant. Poster Board II-578 One of the major revisions in the 2008 WHO classification of “AML…”
Get full text

Adverse Prognostic Impact of FLT3 Internal Tandem Duplication (ITD) Is Age-Associated in Older [≥60 Years (Y)] De Novo cytogenetically Normal Acute Myeloid Leukemia (CN-AML) Patients (Pts): a Cancer and Leukemia Group B (CALGB) Study by Whitman, Susan P., Maharry, Kati, Radmacher, Michael D., Mrózek, Krzysztof, Margeson, Dean, Holland, Kelsi B., Becker, Heiko, Wu, Yue-Zong, Schwind, Sebastian, Baer, Maria R, Powell, Bayard L., Stone, Richard M, Carroll, Andrew J., Larson, Richard A., Caligiuri, Michael A., Marcucci, Guido, Bloomfield, Clara D.

“…Abstract 1579▪▪This icon denotes an abstract that is clinically relevant. Poster Board I-605 While the prognostic role of FLT3 ITD has been validated in…”
Get full text

Comparison of Clinical and Biologic Significance of WT1 Mutations in Populations of Older (≥60 years[y]) and Younger (<60 y) Adult Patients (Pts) with Cytogenetically Normal (CN) De Novo Acute Myeloid Leukemia (AML): a Cancer and Leukemia Group B (CALGB) Study by Becker, Heiko, Marcucci, Guido, Maharry, Kati, Radmacher, Michael D., Mrózek, Krzysztof, Whitman, Susan P., Paschka, Peter, Margeson, Dean, Wu, Yue-Zhong, Schwind, Sebastian, Langer, Christian, Baer, Maria R., Carroll, Andrew J., Caligiuri, Michael A., Kolitz, Jonathan E., Larson, Richard A., Bloomfield, Clara D.

“…Abstract 326▪▪This icon denotes an abstract that is clinically relevant. Mutations of the Wilms tumor (WT1) gene are found in ∼10% of younger (<60 years[y])…”
Get full text

Growth and Development of Premature Infants Fed Predominantly Human Milk, Predominantly Premature Infant Formula, or a Combination of Human Milk and Premature Formula by O'Connor, Deborah L., Jacobs, Joan, Hall, Robert, Adamkin, David, Auestad, Nancy, Castillo, Marcella, Connor, William E., Connor, Sonja L., Fitzgerald, Kathleen, Groh‐Wargo, Sharon, Hartmann, E. Eugenie, Janowsky, Jeri, Lucas, Alan, Margeson, Dean, Mena, Patricia, Neuringer, Martha, Ross, Gail, Singer, Lynn, Stephenson, Terence, Szabo, Joanne, Zemon, Vance

“…ABSTRACT Background In a recent meta‐analysis, human milk feeding of low birth‐weight (LBW) infants was associated with a 5.2 point improvement in IQ tests…”
Get full text